Beta 1 adrenergic receptor Gly389Arg polymorphism and the impact of fixed-dose combination of isosorbide dinitrate/hydralazine in heart failure: Results from the A-HeFT trial

被引：0
|
作者：
McNamara, DM
Tam, SW
Sabolinski, ML
Tobelman, P
Palmer, A
Janosko, K
Feldman, AM
Worcel, M
机构：
[1] NitroMed Inc, Lexington, MA USA
[2] Univ Pittsburgh, Pittsburgh, PA USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2006年 / 47卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：67A / 67A
页数：1
相关论文
共 43 条
  • [21] Effect of Fixed-Dose Combined Isosorbide Dinitrate/Hydralazine in Elderly Patients in the African-American Heart Failure Trial
    Taylor, Anne L.
    Sabolinski, Michael L.
    Tam, S. William
    Ziesche, Susan
    Ghali, Jalal K.
    Archambault, W. Tad
    Worcel, Manuel
    Cohn, Jay N.
    JOURNAL OF CARDIAC FAILURE, 2012, 18 (08) : 600 - 606
  • [22] BUDGET IMPACT ANALYSIS OF FIXED-DOSE ISOSORBIDE DINITRATE AND HYDRALAZINE HYDROCHLORIDE IN TREATMENT OF HEART FAILURE FROM A US MEDICARE POPULATION
    Keum, J.
    Peasah, S. K.
    VALUE IN HEALTH, 2019, 22 : S125 - S125
  • [23] Effects of ACE Inhibitors or ↓-Blockers in Patients Treated with the Fixed-Dose Combination of Isosorbide Dinitrate/Hydralazine in the African-American Heart Failure Trial
    Jalal K. Ghali
    S. William Tam
    Keith C. Ferdinand
    JoAnn Lindenfeld
    Michael L. Sabolinski
    Anne L. Taylor
    Manuel Worcel
    Charles L. Curry
    Jay N. Cohn
    American Journal of Cardiovascular Drugs, 2007, 7 : 373 - 380
  • [24] Effects of ACE inhibitors or β-blockers in patients treated with the fixed-dose combination of isosorbide dinitrate/hydralazine in the African-American Heart Failure Trial
    Ghali, Jalal K.
    Tam, S. William
    Ferdinand, Keith C.
    Lindenfeld, JoAnn
    Sabolinski, Michael L.
    Taylor, Anne L.
    Worcel, Manuel
    Curry, Charles L.
    Cohn, Jay N.
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2007, 7 (05) : 373 - 380
  • [25] Effect of Fixed-Dose Combination of Isosorbide Dinitrate and Hydralazine on All Hospitalizations and on 30-Day Readmission Rates in Patients With Heart Failure Results From the African-American Heart Failure Trial
    Anand, Inder S.
    Win, Sithu
    Rector, Thomas S.
    Cohn, Jay N.
    Taylor, Anne L.
    CIRCULATION-HEART FAILURE, 2014, 7 (05) : 759 - U136
  • [26] Effect of angiotensin converting enzyme inhibitor or beta-blocker use on the benefit of fixed-dose combination of isosorbide dinitrate/hydralazine in the African-American heart failure trial
    Ghali, Jalal K.
    Taylor, Anne L.
    Tam, S. W.
    Sabolinski, Michael L.
    Worcel, Manuel
    Cohn, Jay N.
    CIRCULATION, 2006, 114 (18) : 572 - 572
  • [27] Evidence for the continued safety and tolerability of fixed-dose isosorbide dinitrate/hydralazine in patients with chronic heart failure (the extension to African-American heart failure trial)
    Yancy, Clyde W.
    Ghali, Jalal K.
    Braman, Virginia M.
    Sabolinski, Michael L.
    Worcel, Manuel
    Archambault, W. Tad
    Franciosa, Joseph A.
    AMERICAN JOURNAL OF CARDIOLOGY, 2007, 100 (04): : 684 - 689
  • [28] HYDRALAZINE AND ISOSORBIDE DINITRATE COMBINATION IMPROVES EXERCISE TOLERANCE IN HEART-FAILURE - RESULTS FROM V-HEFT-I AND V-HEFT-II
    ZIESCHE, S
    COBB, FR
    COHN, JN
    JOHNSON, G
    TRISTANI, F
    CIRCULATION, 1993, 87 (06) : 56 - 64
  • [29] β1-adrenergic receptor(Arg389Gly) polymorphism and response to bisoprolol in patients with chronic heart failure
    俞文萍
    ChinaMedicalAbstracts(InternalMedicine), 2006, (04) : 193 - 194
  • [30] Dynamics of echocardiographic parameters in patients with systolic heart failure and Arg389Gly beta1-adrenergic receptor gene polymorphism
    Udovychenko, M.
    Rudyk, I.
    EUROPEAN JOURNAL OF HEART FAILURE, 2013, 12 : S140 - S140
12345